HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Voluntary Cosmetics Reporting Program

This article was originally published in The Rose Sheet

Executive Summary

Voluntary Cosmetics Reporting Program: FDA to publish an advanced notice of proposed rulemaking (ANPR) recommending either the elimination or "significant" modification of the VCRP in the Federal Register in February or March, according to the agency. In November, FDA Office of Cosmetics and Colors Acting Director John Bailey told attendees of the CTFA Scientific Conference that the VCRP annual report card will be eliminated due in part to budget cuts ("The Rose Sheet" Nov. 13, p. 1). FDA's Cosmetic Adverse Reaction Monitoring Program, however, remains a high priority and will be funded, even "at the expense of other" projects, FDA noted...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002430

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel